Grimes & Company, Inc. Exact Sciences Corp Transaction History

Grimes & Company, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$90.24 - $124.05 $180,209 - $247,727	-1,997 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$116.57 - $155.01 $34,621 - $46,037	297 Added 17.47%	1,997 $263,000
Q4 2020 Feb 02, 2021	BUY	$99.61 - $142.12 $169,337 - $241,604	1,700 New	1,700 $225,000
Q3 2019 Nov 05, 2019	SELL	$90.37 - $122.49 $153,629 - $208,233	-1,700 Closed	0 $0
Q2 2019 Jul 30, 2019	BUY	$89.51 - $118.04 $152,167 - $200,668	1,700 New	1,700 $201,000

671

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.16B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Grimes & Company, Inc. with notifications on news.